Blood Management Study for Pediatric Heart Surgery
Treatments studied
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at how managing blood products during heart surgery with a heart-lung machine affects the risk of red blood cell breakdown in children. The goal is to find safer ways to handle blood during these procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 18 years old.
- You are scheduled for heart surgery at Boston Children's Hospital that uses a heart-lung machine.
- You do not have a known disorder that breaks down red blood cells (like sickle cell disease or G6PD deficiency).
- You are not using inhaled nitric oxide before surgery.
- Your blood clotting tests (checked before surgery) are normal.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving blood transfusions based on each patient's needs during and after heart surgery is safe and effective. It compares different transfusion thresholds to see which works better.
This study looks at how much donated blood (blood products) is needed for younger adults during heart surgery that uses a heart-lung machine. It may help doctors choose safer, more appropriate blood-saving plans for people like you.
This trial studies patterns in immune cells (neutrophils) in very young children who undergo heart surgery using a heart-lung machine. The goal is to better understand and potentially reduce lung injury after surgery.
This study looks at whether certain proteins in the blood (called Tau and GFAP) can predict brain injury after heart surgery in children. The goal is to find early warning signs to improve care and outcomes.
This study measures how active white blood cells and inflammation are during complex heart surgery using a heart-lung machine. It may help doctors better understand what triggers inflammation during surgery and how to improve care.
This study looks at tiny particles from cells in newborns with heart defects to understand blood clot risks. It aims to find ways to prevent clots after heart surgery.
Hear when a new Heart Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.